Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.
Skip to main content

Table 2 Stage Two Interview Guide

From: Implementing a clozapine supply service in Australian community pharmacies: barriers and facilitators

1. From your survey response, we understand you do not supply clozapine. What did you think about the regulatory changes that allowed clozapine to be accessed in community pharmacies?

2. Have you considered supplying clozapine in your pharmacy? If yes, why did you choose to not supply?

3. What are your thoughts/opinions on providing clozapine in the community?

4. What do you think are the benefits of supplying clozapine in the community (benefits for both health professionals and consumers)?

5. What do you think are possible issues/concerns supplying clozapine in the community (for both health professionals and consumers)?

6. What support do community pharmacies need to implement clozapine supply services?

Back to article page

Journal of Pharmaceutical Policy and Practice

ISSN: 2052-3211

Contact us